Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) — Net Asset Quality Index
Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) has a Net Asset Quality Index of 96.5% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $514.10 Million minus total liabilities of $18.14 Million yields net assets of $495.96 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of Drugs Made In America Acquisition II Cor for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Drugs Made In America Acquisition II Corp. Ordinary Shares Net Asset Quality Index Over Time (2024–2025)
This chart shows how Drugs Made In America Acquisition II Corp. Ordinary Shares's Net Asset Quality Index has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the index stands at 96.5%, representing net assets of $495.96 Million against total assets of $514.10 Million USD. For live market cap and overall valuation, see Drugs Made In America Acquisition II Cor (DMII) market capitalisation.
Annual Net Asset Quality Index for Drugs Made In America Acquisition II Corp. Ordinary Shares (2024–2025)
The table below presents the year-by-year Net Asset Quality Index for Drugs Made In America Acquisition II Corp. Ordinary Shares from 2024 to 2025, covering 2 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See Drugs Made In America Acquisition II Cor (DMII) shareholders funds for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 96.5% | $487.16 Million | $504.96 Million | $17.80 Million | ▲ +181.0 pp |
| 2024 | -84.5% | $-116.72K | $138.06K | $254.78K | — |